Operating CF
$1.89B
Capex
-$142M
Free Cash Flow
$1.75B
FCF Margin
+92.5%
Cash flow waterfall for ResMed (RMD) — TTM through Q1 2026
Free cash flow: $1.75B
Cash flow breakdown for ResMed (RMD) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $1.89B | $1.89B |
| Capital Expenditure | -$142M | $1.75B |
| Free Cash Flow | $1.75B | $1.75B |
| Acquisitions | -$164M | $1.58B |
| Other Investing | $10.5M | $1.59B |
| Share Buybacks | -$600M | $995M |
| Dividends Paid | -$340M | $654M |
| Other Financing | $32.5M | $687M |
| Forex Effect | $40.9M | $728M |
| Net Cash Increase | $728M | $728M |
- Operating Cash Flow$1.89B
- Capital Expenditure-$142M
- Free Cash Flow$1.75B
- Acquisitions-$164M
- Other Investing$10.5M
- Share Buybacks-$600M
- Dividends Paid-$340M
- Other Financing$32.5M
- Forex Effect$40.9M
- Net Cash Increase$728M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks1.82% TTM
- Dividend Profile1.24% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.